BioCentury
ARTICLE | Financial News

Tvax Biomedical files for IPO

November 8, 2011 1:46 AM UTC

Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) filed to raise up to $40 million in an IPO underwritten by Roth Capital Partners; Cantor Fitzgerald; and Morgan Joseph TriArtisan. Following completi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article